search
Back to results

Safety Study of Post Tonsillectomy Ibuprofen Use in Adults

Primary Purpose

Secondary Post Tonsillectomy Hemorrhage, Primary Post Tonsillectomy Hemorrhage

Status
Unknown status
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Ibuprofen
Sponsored by
Brooke Army Medical Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Secondary Post Tonsillectomy Hemorrhage focused on measuring Post tonsillectomy hemorrhage, post operative hemorrhage, complications, tonsillectomy

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Adults 18 years old or older
  • Scheduled for tonsillectomy

Exclusion Criteria:

  • Prisoners
  • Pregnancy
  • Allergy to ibuprofen
  • History of vasculopathy to include Lupus or Wegener's or Disseminated Intravascular Coagulation (DIC)
  • Any other bleeding disorder to include Von Willebrand Disease and others
  • Active Neoplasm of any kind
  • Tonsillectomy in combination with any sleep surgical procedure or palatal procedure

Sites / Locations

  • Brooke Army Medical CenterRecruiting
  • Wilford Hall Ambulatory Surgical Center
  • Madigan Army Medical Center

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Ibuprofen

Methylcellulose Powder

Arm Description

800mg ibuprofen every 8 hours prn pain.

Subjects receive inert methylcellulose powder as placebo

Outcomes

Primary Outcome Measures

clinically defined tonsil bleed rate (percentage)
A post tonsillectomy hemorrhage/bleed, for the purposes of this study, is defined as a postoperative bleed requiring anything more than medicinal intervention (cauterization of any kind, suture, evaluation in operating room).

Secondary Outcome Measures

Hospital readmission rate (percentage)
Subclinical (not requiring intervention) subjectively reported tonsil bleed rate (percentage)
Subjects will report on followup survey if they had post operative oral bleeding more than streaked blood in their spit for which they did not go to the hospital or clinic for treatment of.
Pain scale rating
Subjects will answer a visual analog scale (VAS) Pain scale for days 1, 3, 7, and 14 after tonsillectomy.
Nausea Scale
Subjects will answer a VAS nausea scale for days 1, 3, and 7 after tonsillectomy.

Full Information

First Posted
April 18, 2013
Last Updated
April 22, 2013
Sponsor
Brooke Army Medical Center
Collaborators
Madigan Army Medical Center, Tripler Army Medical Center, 59th Medical Wing, Blanchfield Army Community Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT01837810
Brief Title
Safety Study of Post Tonsillectomy Ibuprofen Use in Adults
Official Title
NSAID Post-Tonsillectomy Hemorrhage: A Randomized, Double-Blinded Controlled Noninferiority Trial
Study Type
Interventional

2. Study Status

Record Verification Date
April 2013
Overall Recruitment Status
Unknown status
Study Start Date
April 2013 (undefined)
Primary Completion Date
April 2016 (Anticipated)
Study Completion Date
May 2016 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Brooke Army Medical Center
Collaborators
Madigan Army Medical Center, Tripler Army Medical Center, 59th Medical Wing, Blanchfield Army Community Hospital

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of this study is to determine if ibuprofen use after electrocautery tonsillectomy increases the post-tonsillectomy hemorrhage rate. Hypothesis: Use of ibuprofen does not increase the post-tonsillectomy hemorrhage rate. Primary outcome: Rate of tonsillar hemorrhage following adult tonsillectomy in those receiving narcotic pain medications plus ibuprofen compared to those receiving narcotics alone. Secondary outcome: Determine whether ibuprofen, a non-steroidal anti-inflammatory drug (NSAID), decreases post tonsillectomy pain, narcotic pain medication use, or cost of pain management.
Detailed Description
Tonsillectomy is common procedure associated with significant post-operative pain typically managed by narcotic pain medication. Narcotics, however, can have inherent unwanted side effects such as respiratory depression. In fact, a recent U.S. Food and Drug Administration (FDA) warning has reported deaths from respiratory distress that were associated with use of codeine in children after tonsillectomy. Finding alternative pain management regimens therefore is essential in post-tonsillectomy care. Non-steroidal anti-inflammatory (NSAID) medications may provide an effective alternative to narcotics, but use of NSAIDs routinely after tonsillectomy has been limited due to concern for theoretical increased risk of post-operative bleeding, This is likely true for NSAIDs such as aspirin. NSAIDs such as ibuprofen, however, are believed to have no greater risk of bleeding than baseline, but this has not been proven. Recent, well-designed, prospective pediatric studies have demonstrated effective analgesia improvement with the addition of non-steroidal anti-inflammatory drugs such as ibuprofen to post-operative pain management regimens, and no increased rate of post-surgery bleeding. This has not adequately been studied in adults but could provide many patients significant pain relief in the post-operative period if it is shown to not increase post tonsillectomy hemorrhage rates, as already demonstrated in the pediatric population.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Secondary Post Tonsillectomy Hemorrhage, Primary Post Tonsillectomy Hemorrhage
Keywords
Post tonsillectomy hemorrhage, post operative hemorrhage, complications, tonsillectomy

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigator
Allocation
Randomized
Enrollment
810 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Ibuprofen
Arm Type
Experimental
Arm Description
800mg ibuprofen every 8 hours prn pain.
Arm Title
Methylcellulose Powder
Arm Type
Placebo Comparator
Arm Description
Subjects receive inert methylcellulose powder as placebo
Intervention Type
Drug
Intervention Name(s)
Ibuprofen
Other Intervention Name(s)
Advil, Motrin
Intervention Description
800mg every 8 hours as needed for pain
Primary Outcome Measure Information:
Title
clinically defined tonsil bleed rate (percentage)
Description
A post tonsillectomy hemorrhage/bleed, for the purposes of this study, is defined as a postoperative bleed requiring anything more than medicinal intervention (cauterization of any kind, suture, evaluation in operating room).
Time Frame
2 weeks
Secondary Outcome Measure Information:
Title
Hospital readmission rate (percentage)
Time Frame
2 weeks
Title
Subclinical (not requiring intervention) subjectively reported tonsil bleed rate (percentage)
Description
Subjects will report on followup survey if they had post operative oral bleeding more than streaked blood in their spit for which they did not go to the hospital or clinic for treatment of.
Time Frame
2 weeks
Title
Pain scale rating
Description
Subjects will answer a visual analog scale (VAS) Pain scale for days 1, 3, 7, and 14 after tonsillectomy.
Time Frame
2 Weeks
Title
Nausea Scale
Description
Subjects will answer a VAS nausea scale for days 1, 3, and 7 after tonsillectomy.
Time Frame
2 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Adults 18 years old or older Scheduled for tonsillectomy Exclusion Criteria: Prisoners Pregnancy Allergy to ibuprofen History of vasculopathy to include Lupus or Wegener's or Disseminated Intravascular Coagulation (DIC) Any other bleeding disorder to include Von Willebrand Disease and others Active Neoplasm of any kind Tonsillectomy in combination with any sleep surgical procedure or palatal procedure
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Gregory R Dion, MD, MS
Phone
210-916-8040
Email
gregory.r.dion.mil@mail.mil
First Name & Middle Initial & Last Name or Official Title & Degree
Thomas J Willson, MD
Phone
210-916-2367
Email
thomas.j.willson.mil@mail.mil
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Gregory R Dion, MD, MS
Organizational Affiliation
San Antonio Military Medical Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
Brooke Army Medical Center
City
Fort Sam Houston
State/Province
Texas
ZIP/Postal Code
78234
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Gregory R Dion, MD, MS
Phone
210-916-8040
Email
gregory.r.dion.mil@mail.mil
First Name & Middle Initial & Last Name & Degree
Gregory R Dion, MD, MS
Facility Name
Wilford Hall Ambulatory Surgical Center
City
Lackland AFB
State/Province
Texas
ZIP/Postal Code
78236
Country
United States
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Thomas J Willson, MD
Phone
210-916-2367
Email
thomas.j.willson.mil@mail.mil
First Name & Middle Initial & Last Name & Degree
Thomas J Willson, MD
Facility Name
Madigan Army Medical Center
City
Tacoma
State/Province
Washington
ZIP/Postal Code
98431
Country
United States
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Del R Sloneker, MD
Phone
253-968-1420
Email
del.r.sloneker.mil@mail.mil
First Name & Middle Initial & Last Name & Degree
Del R Sloneker, MD

12. IPD Sharing Statement

Learn more about this trial

Safety Study of Post Tonsillectomy Ibuprofen Use in Adults

We'll reach out to this number within 24 hrs